CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Tscan Therapeutics (TCRX) Financial Analysis | CapyFin

Tscan Therapeutics

TCRX · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings 27 days ago

Previous year: $665K

Previous year: -$0.3

Weighted Avg Shares

Previous year: 120.79M

Cash and Equivalents

Previous year: $179M

Previous year: $371M

Loading...

Tscan Therapeutics

Unlock previous datapoints

Tscan Therapeutics

Unlock previous datapoints

Tscan Therapeutics Revenue by Segment

Revenue by Segment

Collaboration & License Revenue

Unlock previous datapoints

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$56.2M

P/E Ratio

-0.94

Sector

N/A

Industry

N/A

52-Week High

$2.5

52-Week Low

$0.881

Weighted Avg Shares

129.86M